Bioorganic and Medicinal Chemistry Letters p. 3038 - 3041 (2016)
Update date:2022-08-05
Topics:
Yoon, Suyoung
Kim, Jong Hyun
Yoon, Ina
Kim, Changhoon
Kim, Sung-Eun
Koh, Yura
Jeong, Seung Jae
Lee, Jiyoun
Kim, Sunghoon
Lee, Jeewoo
A series of leucinol analogs were investigated as leucyl-tRNA synthetase-targeted mTORC1 inhibitors. Among them, compound 5, (S)-4-isobutyloxazolidin-2-one, showed the most potent inhibition on the mTORC1 pathway in a concentration-dependent manner. Compound 5 inhibited downstream phosphorylation of mTORC1 by blocking leucine-sensing ability of LRS, without affecting the catalytic activity of LRS. In addition, compound 5 exhibited cytotoxicity against rapamycin-resistant colon cancer cells, suggesting that LRS has the potential to serve as a novel therapeutic target.
View MoreHEZE KINGVOLT CHEMICAL CO., LTD
Contact:86-573-82118911
Address:Juancheng Industry Park
Contact:+86-21-6856-1349 523-87676172
Address:No16 . BinJiang Road . Taixing Economy Developing Area .JiangSu Province . China
HUNAN CHEMAPI BIOLOGICAL TECHNOLOGY CO.,LTD.
Contact:+86-186-02659358
Address:1004, building 3, Wanke Jinsemaitianyuan, 498 Guitang Road, Yuhua District, Changsha City, Hunan Province, China
PharmaResources(Kaiyuan)CO,.Ltd
Contact:+86-21-50720028
Address:No.3, Beihuan Road, Economic Development District, Kaiyuan City, Tieling City, Liaoning Province, China 112300
SHIJIAZHUANG HENRYTE CHEMICALS CO,.LTD(expird)
Contact:+86-311-85208698 311-80837698
Address:NO.166, yuhua west road, SHIJIAZHUANG, China
Doi:10.1021/jo502181a
(2014)Doi:10.1021/jm00304a015
(1969)Doi:10.1021/jo990061j
(1999)Doi:10.1007/s11172-008-0260-z
(2008)Doi:10.1016/S0277-5387(03)00478-9
(2003)Doi:10.1016/j.tetlet.2006.03.073
(2006)